Biogen (BIIB) Tops Q2 EPS by $1.62, Raises FY Guidance
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $225.36 --0%
Revenue Growth %: +4.3%
Financial Fact:
Basic earnings per share attributable to Biogen Idec Inc.: 218.9M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +4.3%
Financial Fact:
Basic earnings per share attributable to Biogen Idec Inc.: 218.9M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q2 EPS of $9.15, $1.62 better than the analyst estimate of $7.53. Revenue for the quarter came in at $3.6 billion versus the consensus estimate of $3.48 billion.
GUIDANCE:
Biogen sees FY2019 EPS of $31.50-$32.30, versus the consensus of $29.70. Biogen sees FY2019 revenue of $14-14.2 billion, versus the consensus of $13.95 billion.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance
- Activist Jana Partners calls for Six Flags sale - WSJ
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
